# Biomarin Pharmaceutical Inc. (BMRN) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $409M |
| 2024 | $484M |
| 2023 | $186M |
| 2022 | $161M |
| 2021 | -$82M |
| 2020 | -$43M |
| 2019 | -$100M |
| 2018 | -$124M |
| 2017 | -$15M |
| 2016 | -$803M |
| 2015 | -$111M |
| 2014 | -$93M |
| 2013 | -$156M |
| 2012 | -$110M |
| 2011 | -$34M |
| 2010 | $544,000 |
| 2009 | $16M |
| 2008 | $40M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $130M |
| 2025-09-30 | -$47M |
| 2025-06-30 | $277M |
| 2025-03-31 | $224M |
| 2024-09-30 | $114M |
| 2024-06-30 | $120M |
| 2024-03-31 | $88M |
| 2023-09-30 | $31M |
| 2023-06-30 | $66M |
| 2023-03-31 | $62M |
| 2022-09-30 | -$2M |
| 2022-06-30 | $39M |
| 2022-03-31 | $137M |
| 2021-09-30 | -$53M |
| 2021-06-30 | $12M |
| 2021-03-31 | $25M |
| 2020-09-30 | -$56M |
| 2020-06-30 | -$41M |
| 2020-03-31 | $105M |
| 2019-09-30 | $4M |
| 2019-06-30 | -$41M |
| 2019-03-31 | -$54M |
| 2018-09-30 | -$16M |
| 2018-06-30 | -$25M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/BMRN/operating-income)